Stockwatch: Sentimental journeys
This article was originally published in Scrip
Executive Summary
This week has seen the third quarter results from, among others, three of the pharmaceutical industry's more interesting companies. AstraZeneca's and Bristol-Myers Squibb's results were published on 27 October, following Lilly's a week earlier on 20 October.